SYNERGIE GENE+ OUTCOMES

Administering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service